BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

NCT05363709 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped 0 participants

Conditions

HPV
Oropharyngeal Cancer

Interventions

DRUG: Balstilimab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]